Kyle Rasbach - Chief Financial Officer at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
LXEO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kyle Rasbach since 12/5/2024

Holdings reported by Kyle Rasbach for Lexeo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 40.9K $335K $8.20 Jan 17, 2025 Direct
Stock Option (right to buy) 245K Jan 17, 2025 Direct Common Stock

Transactions reported by Kyle Rasbach for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.